Get in touch

Publications & News

Stay updated with our latest articles, reports, and news releases.

Contact us

Publications

Practice area
Sort by
Impact assessment, CBA & Policy Evaluation

2025

Industrial symbiosis: benefits, barriers, risks and costs
The Department for Energy Security and Net Zero commissioned Europe Economics to undertake research to identify and assess the barriers,...

Read more...

Econometrics, Modelling & Quantitative Analysis, Impact assessment, CBA & Policy Evaluation

2025

Estimating the impact on investment of a commercial TDM exception
Europe Economics was commissioned by Computer & Communications Industry Association (CCIA) to quantifiy the impact of a commercial Text and...

Read more...

Econometrics, Modelling & Quantitative Analysis, Impact assessment, CBA & Policy Evaluation

2025

Impact of growth of data centres on energy consumption
Europe Economics was commissioned by the Department for Energy Security and Net Zero (DESNZ) to examine how the growth of...

Read more...

Impact assessment, CBA & Policy Evaluation, Price Control & Regulations

2025

Evaluation of Ofwat's Code for Adoption (CFA) agreements
Europe Economics undertook an evaluation of Ofwat's Code for Adoption (CFA) agreements, which applies to water and sewerage companies that...

Read more...

Impact assessment, CBA & Policy Evaluation

2025

Open banking and open finance in the UK
Earlier in 2025, the Financial Conduct Authority (FCA) commissioned Europe Economics to collate diverse views on open banking and open...

Read more...

Cost of Capital, Price Control & Regulations

2025

WACC update for the Irish mobile, fixed-line, and broadcasting sectors
Europe Economics was commissioned by Commission for Communications Regulation (ComReg) to provide an annual update on the WACC for the...

Read more...

pexels-pixabay
Impact assessment, CBA & Policy Evaluation, Price Control & Regulations

2025

Review of the Industry Risk Fund and Network Rail Fee Fund
Europe Economics undertook a review of the Industry Risk Fund (IRF) and Network Rail Fee Fund (NRFF) for the Office...

Read more...

Competition Policy & Litigation Support, Econometrics, Modelling & Quantitative Analysis, Impact assessment, CBA & Policy Evaluation

2024

DMCC: Economic Impact
Europe Economics was commissioned by Computer & Communications Industry Association (CCIA) to review and critique the UK government’s impact analysis...

Read more...

Econometrics, Modelling & Quantitative Analysis, Price Control & Regulations

2024

Indexation and Efficiency Incentives for Electricity and Natural Gas Distribution in the Regulatory Period from...
The Flemish energy regulator (VREG) commissioned Europe Economics to support the development of its tariff methodology for the Flemish electricity...

Read more...

Econometrics, Modelling & Quantitative Analysis, Price Control & Regulations

2024

Financial incentives for electricity and natural gas distribution in the regulatory period from 2025
The Flemish energy regulator (VREG) commissioned Europe Economics to provide advice on financial incentives that can be used to incentivise...

Read more...

Macroeconomic & Political Analysis

2024

Why the Bank of England must cut interest rates
Our Managing Director Andrew Lilico writes in the Spectator about why the Bank of England ought now to be cutting...

Read more...

Macroeconomic & Political Analysis

2024

Feasibility of taxes rising further after the General Election
Our Managing Director Andrew Lilico writes in the Telegraph about the feasibility or otherwise of taxes rising further after the...

Read more...

Difference-in-difference

Relevant for measuring the impacts of changes in regimes/shocks. It uses observational study data of the same units across time and requires that the units (firms, individuals or countries) are divided into treatment and control groups. Difference-in-difference estimates the effect of an intervention by comparing the average change in the outcome variable experienced by the treated group over time to the average change in the outcome variable experienced by the control group.

Stated preference – survey method which is typically used to identify a person’s willingness to pay. Its key advantage is that it enables a monetary value to be placed on certain impacts of a policy or measure.

Ofwat

Our personnel have been seconded multiple times to Ofwat, and we have carried out various discrete studies analysing the water sector from different perspectives. Some of these have involved cost assessment support for RAPID gate two assessment; advising on important aspects of Ofwat’s approach to the cost of equity for PR24 and; assisting with the investigation of the potential for improving Ofwats’s methodology to mergers’ assessment.

European Commission, DG CLIMA

We have conducted several studies for DG CLIMA relating to the European Union’s emissions trading system.   For example, we conducted a study looking at the impact of changes in trading activity on the price formation processes in the European carbon market, the access to the market for retail investors, which included also the access via exchange traded funds (ETFs), the hedging strategies of EU emissions trading system (ETS) compliance entities, and the role played by derivatives and financial entities in the EU ETS.

Danish Energy Regulator (Energistyrelsen)

We looked at how a benchmarking model used to help set price controls by the Energistyrelsen on DSOs might affect the Green Transition.  We looked at the challenges facing DSOs in the Green Transition and what behaviours should be incentivised.  We then looked at how the benchmarking model and wider regulatory framework might affect those incentives.  This included developing a number of worked examples to consider how the benchmarking model might affect incentives to invest in network expansion, faster connections or flexibility solutions. 

Zero Waste Scotland

Europe Economics was engaged by Zero Waste Scotland (ZWS) to estimate how potential efficiency savings in water and energy are likely to be distributed across firms of different sizes and ownership structures in Scotland. The aim was to inform ZWS policy of where to target resource saving initiatives; in particular whether potential savings were sufficiently concentrated among SMEs to warrant specific effort among these.

We was also engaged by ZWS to estimate the costs and benefits of proposed market restrictions on specific single-use plastic products in Scotland and to analyse the impacts of the restrictions on competition, consumers and Scottish firms.

Citizens Advice UK

We were commissioned by Citizens Advice UK to investigate the mechanisms that could be used to limit or share the financial risk for energy bill payers in the context of highly anticipatory energy infrastructure investments in GB.

We developed a compendium of risk-allocation tools and, for each, we analysed: the suitability of the mechanism for different types of investments and projects; the extent (and the type) of risk allocated to consumers; the relative advantages and disadvantages of the tool; and how they affect the cost of capital. Each tool also included a case study of the tool being applied in practice.

Professional regulation

Healthcare professionals are the driving force behind the delivery of high-quality care. Outcomes can be affected by external structures and systems as well as individuals’ training and incentives. Economic regulation is one tool that can assist healthcare regulators discern between contextual, clinical and competency risks facing a healthcare profession and its workforce, and develop targeted and cost-effective regulation and training. Our work includes:
  • A seminal assessment of the risks in domiciliary social care and options for revalidation and training to address these risks for the Department of Health, in the context of the Government’s White Paper on non-medical healthcare regulation.
  • Similar assessments of the risks and options for revalidation to address these risks for the General Optical Council; the General Dental Council; and the General Chiropractic Council.
  • A cost-benefit analysis of options for continuing professional development (CPD) for the General Dental Council.
  • Cost-benefit analysis of regulation models for optical businesses for the General Optical Council.

Policy development and impact assessment

As societies and technologies change, it is vital to understand and test the value of medical innovations and new care models. Our expertise in impact assessment and wider understanding of health- and social care markets enable us to advise policy-makers and funders how to prioritise policies and interventions needed to support the delivery of health and medical care. Our work includes:

  • Assessment of the economic, social and innovation impact of Novartis UK. We also undertook as similar study for Novartis Netherlands.
  • Analysis of regulatory models of telemedicine for the General Medical Council.
  • Assessment of the value and savings attributable to Look Ahead’s integration social care and housing model.

Intellectual property and pricing

We understand the importance of protecting intellectual property in pharmaceuticals and incentivising innovation, and the need to provide cost-effective access to medicines and healthcare. We advise on the design and impact of intellectual property policies and payment and reimbursement systems within the challenges and opportunities of a European and global pharmaceuticals market, applying learning from other regulated sectors. Our work includes:

  • For Merck Sharp and Dohme, an assessment of the practice of importing patented medicines across Europe, and the implications for the market of increased transparency of prices.
  • We delivered a study to Efpia on the impacts on the EU of the exclusion of patent extension provisions, in respect of medicines, from the forthcoming EU-MERCOSUR free trade agreement.
  • We produced a report for EuropaBio on the costs to the European patented medicines sector from a change on the current SPC framework.
  • For the European Patent Office, we studied the economic effects of introducing a grace period in Europe using as the main source of information a survey of those that have filed for patent protection in Europe the US and Japan.
  • Amongst our many projects on parallel trade, we have done four major studies for the European Commission on aspects of parallel trade relating to patient safety and counterfeiting, in both the medicines and medical devices sectors.